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The palmitoyl transferase DHHC2 targets a 
dynamic membrane cycling pathway: regulation 
by a C-terminal domain
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aCentre for Integrative Physiology, School of Biomedical Sciences, University of Edinburgh, Edinburgh EH8 9XD, 
United Kingdom; bStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow 
G4 0RE, United Kingdom
ABSTRACT Intracellular palmitoylation dynamics are regulated by a large family of DHHC 
(Asp-His-His-Cys) palmitoyl transferases. The majority of DHHC proteins associate with endo-
plasmic reticulum (ER) or Golgi membranes, but an interesting exception is DHHC2, which 
localizes to dendritic vesicles of unknown origin in neurons, where it regulates dynamic palm-
itoylation of PSD95. Dendritic targeting of newly synthesized PSD95 is likely preceded by 
palmitoylation on Golgi membranes by DHHC3 and/or DHHC15. The precise intracellular 
distribution of DHHC2 is presently unclear, and there is very little known in general about 
how DHHC proteins achieve their respective localizations. In this study, membrane targeting 
of DHHC2 in live and fixed neuroendocrine cells was investigated and mutational analysis 
employed to define regions of DHHC2 that regulate targeting. We report that DHHC2 associ-
ates with the plasma membrane, Rab11-positive recycling endosomes, and vesicular struc-
tures. Plasma membrane integration of DHHC2 was confirmed by labeling of an extrafacial 
HA epitope in nonpermeabilized cells. Antibody-uptake experiments suggested that DHHC2 
traffics between the plasma membrane and intracellular membranes. This dynamic localiza-
tion was confirmed using fluorescence recovery after photo-bleaching analysis, which re-
vealed constitutive refilling of the recycling endosome (RE) pool of DHHC2. The cytoplasmic 
C-terminus of DHHC2 regulates membrane targeting and a mutant lacking this domain was 
associated with the ER. Although DHHC2 is closely related to DHHC15, these proteins popu-
late distinct membrane compartments. Construction of chimeric DHHC2/DHHC15 proteins 
revealed that this difference in localization is a consequence of divergent sequences within 
their C-terminal tails. This study is the first to highlight dynamic cycling of a mammalian DHHC 
protein between clearly defined membrane compartments, and to identify domains that 
specify membrane targeting of this protein family.
INTRODUCTION
S-palmitoylation, the attachment of long-chain fatty acids (predom-
inantly palmitate, C16:0) onto cysteine residues, is a posttransla-
tional modification occurring on a diverse array of cellular proteins 
(Kang et al., 2008). Our understanding of the cell biology of palmi-
toylation is advancing rapidly, with research on distinct cells and 
systems converging to highlight key regulatory mechanisms attrib-
utable to this lipid modification (for reviews, see Greaves and 
Chamberlain, 2007; Linder and Deschenes, 2007; Greaves et al., 
2009; Fukata and Fukata, 2010; Salaun et al., 2010). Protein 
palmitoylation has been shown to regulate 1) membrane binding; 
2) the precise membrane micro-localization of proteins; 3) protein 
traffic and sorting; 4) protein–protein interactions; and 5) protein 
stability.
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Protein palmitoylation is a reversible process and many proteins 
undergo constitutive or regulated changes in palmitoylation status. 
A small number of depalmitoylating enzymes have been identified, 
although the contribution made by these proteins to cellular palmi-
toylation dynamics is not clear (Duncan and Gilman, 1998; Dekker 
et al., 2010). In contrast to this sketchy understanding of depalmi-
toylation, recent studies identified a family of 23 mammalian DHHC 
(Asp-His-His-Cys) palmitoyl transferases (Fukata et al., 2004; Huang 
et al., 2004; Keller et al., 2004). Genetic analyses in yeast have found 
that DHHC proteins are responsible for the bulk of palmitoylation 
reactions that occur in cells (Roth et al., 2006). The defining feature 
of DHHC proteins is the presence of a 51 amino acid cysteine-rich 
domain, which includes a largely invariant DHHC motif (Putilina et 
al., 1999; Lobo et al., 2002; Roth et al., 2002). The DHHC domain is 
critical for palmitoyl transferase activity, and is present within a cyto-
plasmic loop of these polytopic membrane proteins (Mitchell et al., 
2006). The palmitoylation reaction appears to involve a two-step 
process that proceeds via a DHHC-palmitate intermediate (Mitchell 
et al., 2010), and the integrity of the DHHC motif is also important 
for autopalmitoylation of DHHC proteins (Greaves and Chamberlain, 
2011).
Recent studies have shown that many peripheral proteins un-
dergo dynamic cycling between the Golgi and the plasma mem-
brane, which is regulated by palmitoylation–depalmitoylation dy-
namics (Goodwin et al., 2005; Rocks et al., 2005, 2010). Palmitoylation 
of these proteins is proposed to occur exclusively at the Golgi, fa-
cilitating stable membrane interaction and traffic to post-Golgi com-
partments. Subsequent depalmitoylation results in membrane re-
lease and cytosolic exchange, and is followed by repalmitoylation 
at the Golgi. Thus it is proposed that Golgi DHHC proteins play a 
major function in directing anterograde traffic of peripheral palmi-
toylated proteins. In contrast to the central function performed by 
Golgi DHHC proteins in palmitoylation of peripheral membrane 
proteins, far less is known about the role of specific DHHC proteins 
in regulating palmitoylation dynamics at post-Golgi compartments.
A recent study reported that DHHC2 localizes to mobile vesicles 
in dendrites, which respond to changes in synaptic activity by trans-
locating toward the plasma membrane, regulating dynamic palmi-
toylation of the postsynaptic scaffold protein PSD-95 (Noritake 
et al., 2009). However, the identity and nature of these vesicles was 
not determined, and it is not clear whether DHHC2 remains associ-
ated with vesicles or if these vesicles undergo fusion with the plasma 
membrane; fusion would result in integration of DHHC2 into the 
plasma membrane. The delivery of newly synthesized PSD-95 to 
dendritic regions likely requires prior palmitoylation on Golgi mem-
branes, which would facilitate stable membrane binding and synap-
tic targeting. PSD-95 is a substrate for Golgi enzymes, including 
DHHC3, DHHC7, and DHHC15 (Fukata et al., 2004). DHHC3 was 
reported to contribute to constitutive palmitoylation of PSD-95 in 
hippocampal neurons (Noritake et al., 2009). In neuroendocrine 
PC12 cells, DHHC2 decorates the plasma membrane and an un-
identified intracellular compartment visualized by confocal imaging 
(Greaves et al., 2010); possible targets of DHHC2 in this cell type 
include the soluble N-ethylmaleimide-sensitive factor attachment 
protein receptor (SNARE) membrane fusion synaptosomal-associ-
ated proteins (SNAP) SNAP25 and SNAP23 (Greaves et al., 2010). 
To fully delineate the functions of DHHC2 and to understand regu-
lated trafficking of this protein, it is essential to characterize the 
membrane interaction dynamics of this protein. Furthermore, un-
derstanding how DHHC2 localization is achieved is an important 
step toward uncovering the mechanisms that define intracellular 
patterning of the DHHC protein family. These questions are particu-
larly relevant, as recent work suggested that DHHC2 is one of the 
major DHHC isoforms expressed in neuroendocrine cells and in 
mouse brain at the mRNA level (Jia et al., 2011).
RESULTS
DHHC2-EGFP localizes to the plasma membrane, recycling 
endosomes, and vesicles
We recently reported that murine DHHC2 expressed in PC12 cells 
associates with the plasma membrane and an unidentified intracel-
lular compartment (Greaves et al., 2010). This localization was unaf-
fected by the size (hemagglutinin [HA] or enhanced green fluores-
cent protein [EGFP]) or the location (N- or C-terminal) of the tag. To 
identify the compartment(s) with which DHHC2 associates, we ex-
amined codistribution with markers of recycling endosomes (Rab11), 
Golgi (GM130), and trans-Golgi network (TGN38) (Figure 1A). Clear 
overlap of DHHC2 was observed with Rab11 but not with either 
GM130 or TGN38; this was confirmed by quantitative analysis of 
fluorescence intensity covariance (Figure 1A). Triple labeling experi-
ments also revealed the physical separation of DHHC2-EGFP from 
both Golgi (Grasp55) and trans-Golgi (TGN38) membranes (Figure 
1B), whereas cotransfection with mCherry-Rab11 highlighted asso-
ciation of DHHC2-EGFP with recycling endosomes (Figure 1C). In 
addition to the plasma membrane and recycling endosomes, 
DHHC2 was also associated with vesicular structures in the cyto-
plasm. Human DHHC2 displayed the same localization as murine 
DHHC2 (Figure 1D).
To determine whether the plasma membrane/endosomal local-
ization of DHHC2 in PC12 cells is also observed in other cell types, 
DHHC2-EGFP was transfected into HEK293 cells. Figure 2A shows 
that DHHC2 associated with the plasma membrane and an intracel-
lular compartment in HEK293 cells. Staining of the Golgi (GM130) 
and recycling endosomes (Rab11) revealed that DHHC2 was indeed 
associated with a Rab11-positive compartment in this cell type 
(Figure 2B).
Plasma membrane integration of DHHC2
To ensure that the plasma membrane signal detected for DHHC2-
EGFP reflected the true integration of DHHC2 into this membrane, 
we created a DHHC2 construct with an HA epitope inserted into the 
predicted extrafacial loop between transmembrane helices 3 and 4 
(Figure 3A). The presence of the HA epitope did not affect the local-
ization of DHHC2-EGFP as judged by colocalization with DHHC2-
mCherry (Figure 3B). If DHHC2 is properly inserted into the plasma 
membrane, the HA epitope should be accessible to antibody added 
to intact cells. Thus cells expressing DHHC2-HA-EGFP were fixed 
and incubated in the presence or absence of 0.2% Triton X-100, and 
then incubated with a monoclonal HA antibody. In nonpermeabi-
lized cells, the HA antibody decorated the plasma membrane but 
was absent from the recycling endosome (RE) compartment 
(Figure 3C, Top). However, in permeabilized cells, the antibody 
labeled both the plasma membrane and recycling endosomes 
(Figure 3C, Bottom). This analysis clearly shows that the HA epitope 
of plasma membrane-associated DHHC2 is accessible on nonper-
meabilized cells and, therefore, that the protein is integrated into 
the plasma membrane. In addition, this result provides experimental 
support to the predicted membrane topology for DHHC2 that is 
illustrated in Figure 3A.
Membrane cycling of DHHC2
When live PC12 cells expressing DHHC2-HA-mCherry were incu-
bated with an Alexa Fluor 488–conjugated HA antibody, we ob-
served a time-dependent accumulation of the antibody on 
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(FRAP). For FRAP analysis, the intracellular fluorescence was selec-
tively photo-bleached, and fluorescence recovery of the RE com-
partment was monitored over time (Figure 4). Measuring the ratio of 
fluorescence of the RE pool (FRE) against the remainder of the total 
intracellular membranes (Figure 3D), suggesting that DHHC2 might 
cycle between the plasma membrane and endosomes. To further 
investigate whether the localization of DHHC2 is dynamically regu-
lated, we employed fluorescence recovery after photo-bleaching 
FIGURE 1: Intracellular localization of DHHC2-EGFP in PC12 cells. (A) PC12 cells transfected with DHHC2-EGFP were 
labeled with antibodies against Rab11, GM130, or TGN38, and then with Alexa Fluor 633–conjugated secondary 
antibodies. Representative images are shown in the top three panels. Pearson’s r values denoting covariance of 
fluorescence signals were calculated using Image J software and results show average values ± SEM (n = 6 or 7 cells for 
each condition). The correlation coefficient for DHHC2-EGFP and Rab11 was significantly greater than values obtained 
for DHHC2-EGFP against GM130 and TGN38 (p < 0.001, one-way analysis of variance [ANOVA]). (B) PC12 cells 
transfected with DHHC2-EGFP were labeled with antibodies against Grasp55 (sheep) and TGN38 (mouse), and then 
with anti-sheep(543)and anti–mouse(633) secondary antibodies. (C) PC12 cells were cotransfected with DHHC2-EGFP 
and mCherry-Rab11 and representative confocal images are shown. (D) Localization of mouse DHHC2-EGFP and human 
DHHC2-mCherry cotransfected in PC12 cells. Scale bars on all figure panels represent 5 μm.
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FIGURE 2: Intracellular localization of DHHC2-EGFP in HEK293 cells. (A) Representative image showing association of 
DHHC2-EGFP with the plasma membrane and an intracellular compartment in HEK293 cells. (B) HEK293 cells 
transfected with DHHC2-EGFP were labeled with mouse GM130 and rabbit Rab11 antibodies and subsequently with 
anti-mouse(543) and anti-rabbit(633). Scale bars on all figure panels represent 5 μm.
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dynamic, and there most likely is cycling of the protein between the 
plasma membrane and endosomes.
Intracellular localization of DHHC2 is regulated 
by a C-terminal domain
There has been little previous analysis of the targeting features that 
govern DHHC protein localization. Given our reported localization 
of DHHC2 to a dynamic membrane cycling pathway in PC12 cells, 
we next investigated how targeting to this pathway is achieved. 
Palmitoylation of many DHHC substrate proteins regulates their in-
tracellular targeting. Thus, as a starting point, we examined the pos-
sibility that intramolecular autopalmitoylation of DHHC2 might be 
important for targeting to the plasma membrane and recycling en-
dosomes. To test this, we examined a DHHC2-EGFP construct 
cellular fluorescence (FCELL − FRE) revealed that the RE pool of 
DHHC2-EGFP recovered from 6 ± 0.3% to 62.8 ± 4.3% of the start-
ing fluorescence intensity value within 20 min following photo-
bleach. This analysis shows the localization of DHHC2-EGFP is 
FIGURE 3: Integration of DHHC2 into the plasma membrane and 
evidence of recycling. (A) Illustration of the predicted membrane 
topology of DHHC2 at the plasma membrane, highlighting the 
position of the inserted HA epitope and EGFP fluorescent tag. 
(B) Comparison of the intracellular localization of DHHC2-HA-EGFP 
and DHHC2-mCherry constructs cotransfected into PC12 cells. 
(C) PC12 cells transfected with the DHHC2-HA-EGFP construct were 
fixed and incubated in the absence (− TX100) or presence (+ TX100) 
of Triton X-100 for 6 min. The cells were then incubated with a mouse 
monoclonal HA antibody and subsequently with anti-mouse(633). 
(D) PC12 cells expressing DHHC2-HA-mCherry were incubated with 
anti-HA conjugated to Alexa Fluor 488 for 30 min at room 
temperature. The cells were then imaged directly, incubated on the 
microscope stage at 37°C for a further 60 min, and imaged again 
using identical settings. Scale bars on all figure panels represent 5 μm.
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FIGURE 4: Evidence for plasma membrane-to-endosome cycling of 
DHHC2-EGFP. (A) DHHC2-EGFP fluorescence present within the 
cytosolic space was photo-bleached as described in Materials and 
Methods. Top, comparison of the left and middle image panels shows 
the fluorescence signal that was photo-bleached. Fluorescence 
recovery was monitored by acquiring images every 10 s after 
photo-bleaching, and representative images are shown prebleach, 
immediately following photo-bleaching (t = 0) and after 5, 10, 15, and 
20 min of recovery. Scale bars represent 5 μm. (B) The fluorescence 
intensities of the RE compartment (FRE) and the whole cell (FCELL) 
were calculated using Image J software, and presented as a 
normalized ratio of FRE/(FCELL − FRE) (n = 10 cells). The figure inset 
depicts example regions that would be selected for analysis.
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signs of aggregation (Figure 6B), suggesting that the protein is 
folded and stable. The EGFP-DHHC2(1–240) mutant displayed a 
similar ER-like localization as the mutant with a C-terminal EGFP tag, 
and its distribution was quantifiably distinct from full-length mCherry-
DHHC2 in cotransfection experiments (Figure 6C). Finally, we 
checked whether similar C-terminal truncations in other DHHC pro-
teins also cause ER retention. Truncation of DHHC3 15 amino acids 
downstream of the final predicted TMD (DHHC3(1–250)) had no ef-
fect on the targeting of this protein to Golgi membranes and did not 
cause ER retention; thus an intact C-terminal domain is not required 
for ER exit of all DHHC proteins.
DHHC2 shares high sequence identity with DHHC15, which is 
nevertheless localized to Golgi-like membranes (Greaves et al., 
2008). It is interesting to note that despite the similarity of DHHC2 
and DHHC15, the protein sequences diverge in the final half of the 
C-terminal tail (Figure 7A). We therefore reasoned that the distinct 
localizations of DHHC2 and DHHC15 might be due to these diver-
gent regions in the C-termini of the proteins. To test this idea, we 
swapped the C-terminal regions of DHHC2 and DHHC15 down-
stream of amino acid N298 in DHHC2 and N301 in DHHC15 (as 
highlighted in Figure 7A), generating DHHC2(15CT) and 
DHHC15(2CT) mutants. All proteins examined in this experiment 
had the EGFP tag placed at the N-terminal side of DHHC2/
DHHC15, and the localizations of these proteins were compared to 
mCherry-DHHC2 expressed in the same cell. As expected, EGFP-
DHHC2 and mCherry-DHHC2 displayed a similar distribution (Fig-
ure 7B), whereas EGFP-DHHC15 was clearly present on distinct 
intracellular membranes from DHHC2 and largely absent from the 
plasma membrane (Figure 7C). Interestingly, the DHHC2(15CT) 
mutant displayed an intracellular localization that was distinct from 
mCherry-DHHC2 (Figure 7D). Conversely, adding the C-terminal 
region of DHHC2 onto DHHC15 resulted in a localization of 
DHHC15(2CT) that was similar to DHHC2 (Figure 7E). These results 
imply that the distinct C-terminal domains of DHHC2 and DHHC15 
are responsible for the different intracellular localizations of these 
two related DHHC proteins. The observed changes in localization 
of the chimeric proteins were confirmed by calculating Pearson’s 
correlation coefficient values from multiple transfected cells 
(Figure 7F).
containing a substitution of the cysteine in the DHHC domain with 
an alanine (C156A); mutation of the DHHC motif in this manner 
blocks autopalmitoylation of DHHC proteins. Our previous work 
showed that mutation of the DHHC motif does not have a gross ef-
fect on DHHC2 localization (Greaves et al., 2010). To detect more 
subtle changes in the localization of inactive DHHC2, the 
DHHC2(C156A)-EGFP construct was cotransfected into PC12 cells 
with wild-type DHHC2-mCherry. The representative image shown in 
Figure 5 demonstrates that the localization of wild-type and C156A 
mutant DHHC2 are similar, suggesting that intramolecular auto-
palmitoylation of DHHC2 is not having a major impact on targeting 
of the protein. To provide a quantitative comparison of wild-type 
and C156A mutant targeting to the RE compartment, z projections 
were generated from image stacks of cells expressing either wild-
type or C156A DHHC2-EGFP together with wild-type DHHC2-
mCherry. The fluorescence intensity of the RE compartment (FRE) 
was then expressed as a ratio against the remaining cellular fluores-
cence (FCELL − FRE) for both EGFP and mCherry fluorescence in the 
same cell. The graph presented in Figure 5 demonstrates that there 
was no significant difference in targeting of DHHC2-EGFP wild-type 
or C156A mutant to the RE compartment compared with DHHC2-
mCherry.
DHHC2 is predicted to have a short 16 amino acid N-terminal 
domain, a large intracellular loop containing the DHHC domain, 
and a relatively long cytoplasmic C-terminus (residues 229–366 for 
mouse DHHC2) (Figure 6A). As palmitoylation did not appear to 
regulate intracellular targeting of DHHC2, we next examined 
whether the large C-terminal domain played a role in DHHC2 tar-
geting. Replacing the entire C-terminal domain of DHHC2 with 
EGFP (DHHC2(1–230)-EGFP) led to a redistribution of the protein to 
a compartment that overlapped with the endoplasmic reticulum 
(ER) marker, RFP-ER (Figure 6A). To confirm that this redistribution 
was a result of removal of the C-terminal domain and not caused by 
the EGFP tag, we constructed an additional mutant with an N-termi-
nal EGFP tag (EGFP-DHHC2(1–240)); this mutant also contained a 
short amino acid sequence (residues 230–240) downstream of the 
transmembrane domain (TMD) to limit any disruption of the mem-
brane interaction of the TMD (Figure 6B). This truncation mutant 
expressed at similar levels to full-length DHHC2 and did not show 
FIGURE 5: Effect of mutation of the DHHC motif on localization of DHHC2. (A) DHHC2-mCherry was cotransfected 
into PC12 cells with either DHHC2-EGFP (not depicted) or with DHHC2-EGFP containing a C156A mutation (C156 is the 
cysteine of the DHHC motif). Scale bars represent 5 μm. (B) The fluorescence intensity values of the RE compartment 
and of the whole cell were calculated as described in Materials and Methods for both EGFP and mCherry. The graph 
shows the mean ratio ± SEM of endosomal fluorescence of the EGFP-tagged constructs relative to DHHC2-mCherry 
(n = 7 cells for DHHC2-EGFP, and 5 cells for DHHC2(C156A)-EGFP). A Student’s t test revealed no significant difference 
between RE targeting of wild-type and mutant DHHC2.
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cess, with many proteins undergoing rapid and continuous cycles 
of palmitoylation and depalmitoylation. For proteins such as H- 
and N-Ras, dynamic palmitoylation is thought to involve cytosolic 
diffusion and repalmitoylation on Golgi membranes (Goodwin 
et al., 2005; Rocks et al., 2005). However, many proteins may not 
undergo complete depalmitoylation (and hence cytosolic ex-
change) and dynamic palmitoylation of these proteins might be 
regulated by DHHC proteins beyond the confines of the Golgi 
complex. Two mammalian DHHC proteins that display post-Golgi 
DISCUSSION
The majority of active mammalian DHHC proteins characterized to 
date are localized to Golgi membranes (see Fernandez-Hernando 
et al., 2006; Greaves et al., 2008, 2010). Indeed, a recent study 
highlighted the Golgi as a super-reaction center for palmitoylation 
of peripheral membrane proteins (Rocks et al., 2010). Thus, follow-
ing synthesis, such proteins are palmitoylated at the Golgi, leading 
to stable membrane association and facilitating transport to more 
distal membrane compartments. Palmitoylation is a reversible pro-
FIGURE 6: The C-terminus of DHHC2 regulates intracellular targeting. (A) Schematic of DHHC2 membrane topology, 
and representation of the topology of a DHHC2(1–230)-EGFP construct. Numbers represent amino acid positions. The 
images show PC12 cells cotransfected with DHHC2(1–230)-EGFP and RFP-ER. (B) Schematic of the membrane topology 
of an EGFP-DHHC2(1–240) construct (Top). EGFP-DHHC2 and EGFP-DHHC2(1–240) were transfected into HEK293 
cells. Lysates prepared from transfected cells were resolved by SDS–PAGE and analyzed by immunoblotting with a 
monoclonal GFP antibody (Bottom). Position of molecular weight markers (kDa) are indicated on the left. (C) EGFP-
DHHC2 (Left, Top) or EGFP-DHHC2(1–240) (Left, Bottom) were cotransfected into PC12 cells with mCherry-DHHC2. 
Pearson’s r values showing covariance of the fluorescence intensity of GFP-tagged constructs relative to mCherry-
DHHC2 were calculated using Image J software and results show mean values ± SEM (n = 5 cells for each construct). The 
data were analyzed using a Student’s t test, which revealed a significant difference between DHHC2 and DHHC2(1–240) 
(*** denotes p < 0.001). (D) Confocal images showing the localizations of HA-DHHC3(1–250) stained with HA antibody 
and a mouse secondary antibody conjugated to Alexa Fluor 488, and RFP-ER. Scale bars on all images represent 5 μm.
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A key finding to emerge from the analysis of DHHC2 regulation 
of PSD95 is that DHHC2 activity toward this substrate is affected by 
changes in membrane trafficking of the DHHC protein rather than 
changes in intrinsic activation (Noritake et al., 2009). Because of this, 
it is essential to delineate the precise steady-state and dynamic lo-
calizations of DHHC2. The observation that DHHC2 cycles between 
the plasma membrane and endosomes is of particular relevance to 
the observed movement of DHHC2 in hippocampal neurons 
(Noritake et al., 2009). Total internal reflection fluorescence (TIRF) 
microscopy analysis revealed that DHHC2 vesicles move closer to 
the membrane following synaptic blockade. However, it was not 
clear whether this increased fluorescence reflected insertion of 
DHHC2 into the plasma membrane or if vesicles were just accumu-
lating closer to the cytosolic face of the membrane. The results of 
sorting have been characterized: DHHC5 associates with the plasma 
membrane and the postsynaptic density in neurons (Ohno et al., 
2006; Li et al., 2010), whereas DHHC2 is present on mobile vesicles 
in the dendrites of hippocampal neurons and at the plasma mem-
brane in neuroendocrine PC12 cells (Noritake et al., 2009; Greaves 
et al., 2010). DHHC2 substrates include PSD95, and DHHC2 deple-
tion leads to a loss of activity-dependent changes in palmitoylation 
of this protein. DHHC2 is thought to play a specific role in dynamic 
palmitoylation of PSD95 occurring at synaptic regions, whereas 
synaptic targeting of freshly synthesized PSD95 may be regulated 
by DHHC3 present on the somatic Golgi (Noritake et al., 2009). 
SNAP25 is also a substrate of DHHC2 in HEK293T cells (Greaves 
et al., 2010), although if and how DHHC2 contributes to palmitoy-
lation dynamics of endogenous SNAP25 is not currently known.
FIGURE 7: Analysis of the intracellular localizations of DHHC2 and DHHC15 chimeric proteins. (A) Comparison of the 
amino acid sequences of the C-terminal domains of DHHC2 and DHHC15. The regions of DHHC2 and DHHC15 that 
were swapped to make the DHHC2(15CT) and DHHC15(2CT) chimeras are highlighted (CT). PC12 cells were 
cotransfected with mCherry-DHHC2 together with EGFP-DHHC2 (B), EGFP-DHHC15 (C), EGFP-DHHC2(15CT) (D), or 
EGFP-DHHC15(2CT) (E). F) Pearson’s r values showing covariance of fluorescence intensities of the EGFP-tagged 
constructs relative to mCherry-DHHC2 were calculated using Image J software and results show mean values ± SEM 
(n = 4–6 cells for each construct). The data were analyzed using a one-way ANOVA, which revealed significant 
differences between DHHC2 and DHHC15 (p < 0.001), DHHC2 and DHHC2(15CT) (p < 0.001), DHHC15 and 
DHHC15(2CT) (p < 0.001), DHHC15 and DHHC2(15CT) (p = 0.015), and DHHC2(15CT) and DHHC15(2CT) (p = 0.001). 
Scale bars on images represent 5 μm.
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esis. Human DHHC2 was amplified from HEK293 cell cDNA using 
the following primers: GATCAAGCTTATGGCGCCCTCGGGC-
CCGGG and GATCGTCGACGCAGTCTCATTTTCCATGGTTAATG-
CAG, and cloned into HindIII and Sal1 restriction sites upstream of 
an mCherry tag in the pEGFPN1 vector backbone. The DHHC2-HA-
EGFP vector was made by inserting an HA epitope (KYPYNVPNYA) 
between amino acids F196 and W197 of DHHC2-EGFPN1 using 
site-directed mutagenesis. The DHHC2(15CT) and DHHC15(2CT) 
chimeras were generated within the HA-tagged constructs as fol-
lows: site-directed mutagenesis was used to insert Nhe1 and Sal1 
restriction sites at the boundaries of the domains that were swapped 
(upstream of N298 in DHHC2 and N301 in DHHC15, and down-
stream of the stop codon of each DHHC protein). These regions 
were then swapped by restriction/ligation, and the Nhe1/Sal1 re-
striction sites removed using site-directed mutagenesis. The chime-
ric constructs were amplified by PCR and cloned into pEGFPC2 be-
tween HindIII and Sal1 restriction sites. All mCherry-tagged 
constructs were generated by excising EGFP using Age1 and BsrG1 
restriction enzymes and replacing with mCherry. A GFP-Rab11 con-
struct kindly provided by Giampietro Schiavo (Cancer Research UK 
London Research Institute) was used to generate mCherry-Rab11. 
RFP-ER was from Clontech (San Diego, CA).
Antibodies
Francis Barr (Cancer Research Centre, University of Liverpool, United 
Kingdom) kindly provided a sheep Grasp55 antibody. Monoclonal 
HA antibody (16B12) was purchased from Covance (Emeryville, CA). 
Monoclonal anti-HA (16B12) conjugated to Alex Fluor 488, rabbit 
antibody–recognizing Rab11, and Alexa Fluor–conjugated secondary 
antibodies were purchased from Invitrogen. Monoclonal TGN38 and 
GM130 antibodies were from Becton Dickinson (Oxford, UK). The 
GFP antibody (JL8) used for immunoblotting was from Clontech.
Cell fixation, labeling, and confocal microscopy
Cells were prepared for confocal microscopy or directly analyzed 
∼40 h posttransfection. For most experiments, cells were washed in 
phosphate-buffered saline (PBS) and fixed in 4% formaldehyde for 
30 min at room temperature. For analysis of EGFP/mCherry fluores-
cence, the coverslips were mounted in Mowiol and dried overnight. 
For antibody staining, the cells were washed in PBS containing 0.3% 
bovine serum albumin (BSA) (PBSB) and then permeabilized in PBSB 
containing 0.25% Triton X-100 for 6 min at room temperature. The 
cells were washed and incubated with primary antibodies (1:50) in 
PBSB for 1 h and then with the appropriate Alexa Fluor–conjugated 
secondary antibodies (1:400) for 1 h. The specific antibodies that 
were used for each experiment are indicated in the figure legends. 
Imaging was performed on Zeiss Axiovert and Leica SP5 laser-scan-
ning confocal microscopes. Image data were acquired at Nyquist 
sampling rates and deconvolved using Huygens software (Scientific 
Volume Imaging, Hilversum, The Netherlands). The data were ana-
lyzed using Image J software (http://imagej.nih.gov/ij/download 
.html).
For comparison of targeting of DHHC2-EGFP (wild-type of 
C156A mutant) and DHHC2-mCherry constructs to recycling endo-
somes, summed z projections were generated from image stacks 
and the fluorescence intensities of the RE compartment (FRE) and 
the whole cell (FCELL) were calculated from identical regions of inter-
est for the EGFP and mCherry images. A value of FRE/(FCELL − FRE) 
was calculated for both EGFP and mCherry images and a ratio of 
[FRE/(FCELL − FRE)]EGFP:[FRE/(FCELL − FRE)]mCherry was calculated.
For FRAP analysis, live PC12 cells expressing DHHC2-EGFP were 
maintained at 37°C and 5% CO2. Regions of interest encompassing 
this present study suggest that the observed increase of DHHC2 at 
the membrane is likely to arise due to increased insertion of the 
protein into the plasma membrane, where it can effectively regulate 
PSD95 palmitoylation dynamics. It is particularly interesting that 
DHHC2 localized to Rab11-positive recycling endosomes, as this 
compartment has previously been reported to supply α-amino-3-
hydroxy-5-methyl-4- isoxazole-propionic acid (AMPA) receptors dur-
ing long-term potentiation (Park et al., 2004). It is thus possible that 
neuronal DHHC2 cycles together with AMPA receptors between the 
dendritic plasma membrane and endosomes.
The functions of DHHC2 are not restricted to neuronal cells, 
and this protein has also been shown to regulate tetraspanins 
and cytoskeleton-associated protein 4 (Sharma et al., 2008; 
Planey et al., 2009). Furthermore, a previous study examining 
palmitoyl transferase activity against the cation-dependent man-
nose-6-phosphate receptor concluded that the protein that 
palmitoylates this particular substrate is cycling between the 
plasma membrane and endosomes (Stockli and Rohrer, 2004). 
Thus, given the results reported in the current study, we believe 
that this activity might represent DHHC2, and this possibility 
clearly merits further investigation.
Previous studies examining DHHC2 localization suggested that 
the protein is associated with Golgi membranes (Ohno et al., 2006; 
Sharma et al., 2008). However, it is important that proteins present 
in a pericentriolar localization are thoroughly examined using quan-
titative colocalization with markers of multiple intracellular compart-
ments. This is particularly true when defining localizations with 
Golgi, trans-Golgi network (TGN), and recycling endosomes, as 
these compartments are all present in a similar intracellular location. 
Indeed, a recent study claimed that the major steady-state localiza-
tion of H- and N-Ras is on recycling endosomes (Misaki et al., 2010) 
and not on Golgi membranes, as was previously reported.
There is no information available on how mammalian DHHC pro-
teins target their respective intracellular compartments, and this 
study is the first to highlight trafficking signals in this class of protein. 
Intriguingly, the C-terminal 68 amino acids of DHHC2 and the cor-
responding (albeit shorter) region of DHHC15 were shown to play 
an important role in defining the intracellular localizations of these 
proteins. It will be interesting to determine whether the C-terminus 
of DHHC15 contains Golgi retention signals and/or if the corre-
sponding region of DHHC2 contains active information for targeting 
to the plasma membrane and recycling endosomes. Work is cur-
rently ongoing in our laboratory to more precisely define the target-
ing signals present within this region of DHHC2/DHHC15 and in 
other members of the DHHC protein family.
MATERIALS AND METHODS
Cell culture and transfection
PC12 cells were maintained in RPMI 1640 medium (Life Technolo-
gies) containing 10% horse serum and 5% fetal calf serum (FCS). 
HEK293 cells were maintained in DMEM supplemented with 10% 
FCS. Both cell lines were cultured at 37°C in a humidified atmo-
sphere containing 5% (HEK293) or 7.5% (PC12) CO2. Cells growing 
on poly-d-lysine-coated glass coverslips were transfected with 0.5 μg 
of each plasmid using Lipofectamine 2000 (Invitrogen, Paisley, UK).
Plasmids
Mouse DHHC2 and DHHC15 were amplified from previously de-
scribed constructs (Fukata et al., 2004) and cloned into pEGFPC2 or 
pEGFPN1 vectors between HindIII and Sal1 sites (Clontech, Oxford, 
UK). DHHC2(1–240) was generated by inserting a stop codon at the 
appropriate position in EGFP-DHHC2 using site-directed mutagen-
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the fluorescent signal from the cell cytosol were selected and photo-
bleached for 50 iterations using 100% laser power. The bleached 
cells were then imaged for 20 min at 10-s intervals. Image J software 
was used to calculate fluorescence intensities of the RE compart-
ment (FRE) and whole cell (FCELL) for every time point. These values 
were then converted to a ratio of RE fluorescence against the re-
maining cell fluorescence by calculating FRE/(FCELL − FRE). The data 
were normalized by setting the prebleach value to 100, and all other 
values were expressed relative to this.
Antibody-uptake experiments
PC12 cells expressing DHHC2-HA-mCherry were incubated with 
HA-488 antibody for 30 min at room temperature. The cells were 
then washed and imaged directly; following incubation for 1 h at 
37°C/5% CO2 on the microscope stage, cells were imaged again 
using identical microscope settings.
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